Search research articles
Contact Us
Filters
Showing results (61-70 of 107) with videos related to
Page
of 11
Sort By:
International Journal of Cancer
|
August 15, 1984
Vinblastine and vincristine--growth-inhibitory effects correlate with their retention by cultured Nb 2 node lymphoma cells
P W Gout, R L Noble, N Bruchovsky, et al.
The Journal of Urology
|
December 1, 1988
The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma
S L Goldenberg, N Bruchovsky, P S Rennie, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
November 1, 1996
Induction of cell-free, in vitro transcription by recombinant androgen receptor peptides
R Snoek, P S Rennie, S Kasper, et al.
Der Urologe. Ausg. A
|
February 9, 2000
[Intermittent androgen deprivation]
U W Tunn, N Bruchovsky, H Renneberg, et al.
The Prostate
|
January 1, 1982
Plasminogen activator activity in human prostate and breast tumors: relationship to steroid receptors
P S Rennie, N Bruchovsky, S Mo, et al.
Journal of Steroid Biochemistry
|
March 1, 1989
Prostate. III--A structural feature characteristic of the rat prostate 5 alpha-reductase active site
V Petrow, G M Padilla, A T McPhail, et al.
Urology
|
May 1, 1995
Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report
S L Goldenberg, N Bruchovsky, M E Gleave, et al.
Journal of Cellular Biochemistry
|
May 15, 1998
Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model
M E Gleave, N Sato, M Sadar, et al.
Cancer Research
|
February 1, 1985
Variability of androgen-related phenotypes in the Shionogi mammary carcinoma during growth, involution, recurrence, and progression to hormonal independence
N Bruchovsky, P S Rennie, N Otal, et al.
The Prostate. Supplement
|
January 1, 1996
Control of tumor progression by maintenance of apoptosis
N Bruchovsky, R Snoek, P S Rennie, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 107) with videos related to
Sort By:
Page
of 11
International Journal of Cancer
|
August 15, 1984
Vinblastine and vincristine--growth-inhibitory effects correlate with their retention by cultured Nb 2 node lymphoma cells
P W Gout, R L Noble, N Bruchovsky, et al.
The Journal of Urology
|
December 1, 1988
The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma
S L Goldenberg, N Bruchovsky, P S Rennie, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
November 1, 1996
Induction of cell-free, in vitro transcription by recombinant androgen receptor peptides
R Snoek, P S Rennie, S Kasper, et al.
Der Urologe. Ausg. A
|
February 9, 2000
[Intermittent androgen deprivation]
U W Tunn, N Bruchovsky, H Renneberg, et al.
The Prostate
|
January 1, 1982
Plasminogen activator activity in human prostate and breast tumors: relationship to steroid receptors
P S Rennie, N Bruchovsky, S Mo, et al.
Journal of Steroid Biochemistry
|
March 1, 1989
Prostate. III--A structural feature characteristic of the rat prostate 5 alpha-reductase active site
V Petrow, G M Padilla, A T McPhail, et al.
Urology
|
May 1, 1995
Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report
S L Goldenberg, N Bruchovsky, M E Gleave, et al.
Journal of Cellular Biochemistry
|
May 15, 1998
Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model
M E Gleave, N Sato, M Sadar, et al.
Cancer Research
|
February 1, 1985
Variability of androgen-related phenotypes in the Shionogi mammary carcinoma during growth, involution, recurrence, and progression to hormonal independence
N Bruchovsky, P S Rennie, N Otal, et al.
The Prostate. Supplement
|
January 1, 1996
Control of tumor progression by maintenance of apoptosis
N Bruchovsky, R Snoek, P S Rennie, et al.
Page
of 11